Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Onconetix ( (ONCO) ) has issued an announcement.
On April 20, 2026, Onconetix, Inc. announced that directors Andrew Oakley and Thomas Meier resigned from the board, with Oakley also stepping down as chairman and from all committees and Meier leaving the Compensation Committee, with the company emphasizing their departures were not due to disagreements over operations or governance. Effective April 23, 2026, existing director Sammy Dorf was appointed chairman with an annual stipend, while Josh Epstein, a seasoned executive and legal professional with extensive experience in corporate development, capital markets, and M&A across multiple industries, joined the board and several key committees, a move that strengthens Onconetix’s governance bench and transactional expertise ahead of its 2026 annual meeting.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Onconetix, Inc., a Delaware corporation, operates with a board structure and governance framework typical of publicly traded life sciences or healthcare-related companies, though this announcement focuses solely on its corporate leadership and board composition. The company utilizes standard board committees, including Audit, Compensation, and Nominating and Corporate Governance, reflecting an emphasis on oversight, compliance, and structured strategic direction for its operations and stakeholder interests.
Average Trading Volume: 5,799,868
Technical Sentiment Signal: Sell
Current Market Cap: $461.8K
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.